التفاصيل البيبلوغرافية
| العنوان: |
Male gender is an independent predictor for worse survival and relapse in a large, consecutive cohort of elderly DLBCL patients treated with R‐CHOP. |
| المؤلفون: |
Eyre, Toby A., Martinez‐Calle, Nicolas, Hildyard, Catherine, Eyre, David W., Plaschkes, Hannah, Griffith, John, Wolf, Julia, Fields, Paul A., Gunawan, Arief, Oliver, Rebecca, Booth, Stephen, McMillan, Andrew, Fox, Christopher P., Bishton, Mark, Collins, Graham P., Hatton, Chris S. R. |
| المصدر: |
British Journal of Haematology; Aug2019, Vol. 186 Issue 4, pe94-e98, 5p, 1 Chart, 1 Graph |
| مصطلحات موضوعية: |
GENDER |
| مستخلص: |
The article discusses a 2019 study which shows the male gender to be an independent prognostic adverse factor for progression-free survival (PFS), overall survival (OS) and cumulative relapse risk in elderly de novo diffuse large B-cell lymphoma (DLBCL) patients. It states that potential under-dosing of males becomes significant as the population ages. Also noted is the potential of rituximab in resolving the issue. |
| قاعدة البيانات: |
Complementary Index |
